Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 64, Issue 7_Supplement
1 April 2004
Issue Cover
ISSN 0008-5472
EISSN 1538-7445
In this Issue
Search within issue

Proc Amer Assoc Cancer Res, Volume 45, 2004

Best Abstracts Plenary Session

Carcinogenesis 1: Hormonal Carcinogenesis

Carcinogenesis 10: Signal Transduction and Gene Expression

Carcinogenesis 11: Viral Carcinogenesis

Carcinogenesis 12: Mutagenesis

Carcinogenesis 13: Animal and In Vitro Models of Carcinogenesis II

Carcinogenesis 2: Molecular Carcinogenesis

Carcinogenesis 3: Premalignant Lesions/Oxidative Stress

Carcinogenesis 4: DNA Damage and Repair

Carcinogenesis 5: Animal and In Vitro Models for Carcinogenesis I

Carcinogenesis 6: DNA Damage and Repair I

Carcinogenesis 7: Environmental Carcinogenesis and Tumor Progression

Carcinogenesis 8: Chemical Carcinogenesis

Carcinogenesis 9: Molecular and Viral Carcinogenesis

Cellular, Molecular, and Tumor Biology 1: Angiogenesis Inhibitors I

Cellular, Molecular, and Tumor Biology 100: Activation of Apoptosis by Novel Therapeutic Agents

Cellular, Molecular, and Tumor Biology 101: Adhesion and Signaling in Cancer Progression

Cellular, Molecular, and Tumor Biology 102: Angiogenesis III

Cellular, Molecular, and Tumor Biology 103: Apoptosis Detection and Regulation

Cellular, Molecular, and Tumor Biology 104: Kinase-mediated Cell Survival and Apoptosis

Cellular, Molecular, and Tumor Biology 105: Matrix and Adhesion in Cancer Metastasis I

Cellular, Molecular, and Tumor Biology 106: Matrix and Adhesion in Cancer Metastasis II

Cellular, Molecular, and Tumor Biology 107: Molecular Alterations in Gastrointestinal Tumor Formation

Cellular, Molecular, and Tumor Biology 108: Mouse Models of Human Cancer

Cellular, Molecular, and Tumor Biology 109: Preclinical Science and Imaging in Cancer Models

Cellular, Molecular, and Tumor Biology 110: Protein Kinase C Signaling

Cellular, Molecular, and Tumor Biology 111: Regulation of Apoptosis II

Cellular, Molecular, and Tumor Biology 112: Signaling and Therapeutics III

Cellular, Molecular, and Tumor Biology 113: Cytoplasmic Signaling by Oncogenes and Tumor Suppressors

Cellular, Molecular, and Tumor Biology 114: Molecular and Cellular Determinants of Radiation Response

Cellular, Molecular, and Tumor Biology 115: Nuclear Oncogenes and Tumor Suppressors

Cellular, Molecular, and Tumor Biology 116: Single and Multiple Gene Alterations in Murine Cancer Models

Cellular, Molecular, and Tumor Biology 117: Therapeutic Applications Based on Apoptotic Pathways

Cellular, Molecular, and Tumor Biology 15: Cell and Animal Cancer Models

Cellular, Molecular, and Tumor Biology 16: Cell Cycle Control and Checkpoints

Cellular, Molecular, and Tumor Biology 17: Cell Cycle Targeted Therapeutic Agents

Cellular, Molecular, and Tumor Biology 18: Cytoplasmic Signaling

Cellular, Molecular, and Tumor Biology 19: DNA Methylation: Markers

Cellular, Molecular, and Tumor Biology 2: Angiogenesis Inhibitors II

Cellular, Molecular, and Tumor Biology 20: Genomic Instability

Cellular, Molecular, and Tumor Biology 21: Imaging/Tumor Markers

Cellular, Molecular, and Tumor Biology 22: Mechanisms of Transcriptional Regulation II

Cellular, Molecular, and Tumor Biology 23: Senescence, Telomeres, and Telomerase

Cellular, Molecular, and Tumor Biology 24: Transcriptional Control of Cell Survival

Cellular, Molecular, and Tumor Biology 25: Tumor Microenvironment

Cellular, Molecular, and Tumor Biology 26: Chromatin Structure and Transcriptional Regulation

Cellular, Molecular, and Tumor Biology 27: DNA Methylation Inhibition

Cellular, Molecular, and Tumor Biology 28: Functional Genomics

Cellular, Molecular, and Tumor Biology 29: Gene Expression Studies: Technology, Informatics, and Cancer Biology

Cellular, Molecular, and Tumor Biology 3: Cell Membrane and Cytoplasmic Signaling Pathways

Cellular, Molecular, and Tumor Biology 30: Genome-wide Analysis in Brain Tumors and Animal Models

Cellular, Molecular, and Tumor Biology 31: Genome-wide Screening for Cancer-related Genes I

Cellular, Molecular, and Tumor Biology 32: Genomics/Proteomics to Study Tumor Progression

Cellular, Molecular, and Tumor Biology 33: Inflammation and Metastasis

Cellular, Molecular, and Tumor Biology 34: Molecular Alterations in Genitourinary Tumors

Cellular, Molecular, and Tumor Biology 35: Proteases and Protease Inhibitors

Cellular, Molecular, and Tumor Biology 36: Therapies against Tumor Invasion and Metastasis

Cellular, Molecular, and Tumor Biology 37: Tobacco-related Malignancies: Tumors of the Head and Neck and Lung

Cellular, Molecular, and Tumor Biology 38: Cancer Genetics: Searching for New Genes and Molecular Markers

Cellular, Molecular, and Tumor Biology 39: DNA Repair and Genomic Instability

Cellular, Molecular, and Tumor Biology 40: Proteases and Tumor Invasion

Cellular, Molecular, and Tumor Biology 41: Angiogenesis II: Novel Agents, Mechanisms, and Targets

Cellular, Molecular, and Tumor Biology 42: Genetic Regulation of Metastasis

Cellular, Molecular, and Tumor Biology 43: Oncogenic Transcription Factors

Cellular, Molecular, and Tumor Biology 44: Senescence and Immortalization

Cellular, Molecular, and Tumor Biology 45: Signaling and Therapeutics

Cellular, Molecular, and Tumor Biology 46: Signaling and Tumor Invasion

Cellular, Molecular, and Tumor Biology 47: Analysis of p53-MDM2-ARF Pathways

Cellular, Molecular, and Tumor Biology 48: Angiogenesis I: Inhibitors of VEGF and VEGF-Receptors

Cellular, Molecular, and Tumor Biology 49: Cyclins and Cyclin-dependent Kinases

Cellular, Molecular, and Tumor Biology 50: DNA Damage and Repair II

Cellular, Molecular, and Tumor Biology 51: DNA Damage and Repair III

Cellular, Molecular, and Tumor Biology 52: Molecular Alterations in Prostate Cancer

Cellular, Molecular, and Tumor Biology 53: Molecular Markers I

Cellular, Molecular, and Tumor Biology 54: Pediatric Oncology

Cellular, Molecular, and Tumor Biology 55: Receptor Signaling

Cellular, Molecular, and Tumor Biology 56: Regulatory Mechanisms in Skin Tumorigenesis

Cellular, Molecular, and Tumor Biology 57: Stem Cell Biology

Cellular, Molecular, and Tumor Biology 58: Transcriptional Control of Cellular Activities

Cellular, Molecular, and Tumor Biology 59: Tumor Classification and Genome and Transcriptome Scanning

Cellular, Molecular, and Tumor Biology 60: Angiogenic Gene Expression in Malignancy

Cellular, Molecular, and Tumor Biology 61: Bioinformatics: Genomics, Transcriptomics, and Systems Biology of Cancer

Cellular, Molecular, and Tumor Biology 62: Biomarkers for Metastasis

Cellular, Molecular, and Tumor Biology 63: Biomarkers for Tumor Progression

Cellular, Molecular, and Tumor Biology 64: Bone Metastasis

Cellular, Molecular, and Tumor Biology 65: Cell Surface Death Pathways I

Cellular, Molecular, and Tumor Biology 66: Cell Surface Death Pathways II

Cellular, Molecular, and Tumor Biology 67: Gene Regulation and Tumor Invasion

Cellular, Molecular, and Tumor Biology 68: Genome-wide Screening for Cancer-related Genes II

Cellular, Molecular, and Tumor Biology 69: MAP Kinase Cascade Signaling

Cellular, Molecular, and Tumor Biology 70: Molecular Alterations in Mammary Tumorigenesis

Cellular, Molecular, and Tumor Biology 71: PI3K/ AKT Signaling

Cellular, Molecular, and Tumor Biology 72: Proteomic Pattern Analysis for Cancer Diagnosis and Treatment

Cellular, Molecular, and Tumor Biology 73: Regulation of TRAIL-induced Apoptosis

Cellular, Molecular, and Tumor Biology 74: Regulators of Increased Angiogenesis

Cellular, Molecular, and Tumor Biology 75: siRNA and Gene Silencing

Cellular, Molecular, and Tumor Biology 76: Therapeutic and Diagnostic Marker Discovery Using Proteomics

Cellular, Molecular, and Tumor Biology 77: Cytoplasmic and Nuclear Signaling

Cellular, Molecular, and Tumor Biology 78: Host and Tumor Genomic Instability

Cellular, Molecular, and Tumor Biology 79: Ubiquitin Ligases and Associated Kinases at Key Cell Cycle Checkpoints

Cellular, Molecular, and Tumor Biology 80: Angiogenesis Inhibitors III

Cellular, Molecular, and Tumor Biology 81: Apoptosis-inducing Agents

Cellular, Molecular, and Tumor Biology 82: Cell and Tissue Radiation Biology

Cellular, Molecular, and Tumor Biology 83: DNA Methylation and Chromatin

Cellular, Molecular, and Tumor Biology 84: DNA Methylation: New Genes

Cellular, Molecular, and Tumor Biology 85: Functional Analyses of Nuclear Oncogenes and Tumor Suppressors

Cellular, Molecular, and Tumor Biology 86: Gene Expression

Cellular, Molecular, and Tumor Biology 87: Genetic and Epigenetic Changes in Cancer

Cellular, Molecular, and Tumor Biology 88: Molecular Markers II

Cellular, Molecular, and Tumor Biology 89: Mouse Models of Prostate and Gastrointestinal Cancers

Cellular, Molecular, and Tumor Biology 90: Non-ionizing Radiation

Cellular, Molecular, and Tumor Biology 91: Receptor Tyrosine Kinase Signaling

Cellular, Molecular, and Tumor Biology 92: Regulation of Apoptosis I

Cellular, Molecular, and Tumor Biology 93: Signaling and Therapeutics II

Cellular, Molecular, and Tumor Biology 94: Advances in Proteomics Applied to Cancer Detection and Treatment

Cellular, Molecular, and Tumor Biology 95: Angiogenesis Mechanisms and Microenvironment

Cellular, Molecular, and Tumor Biology 96:: Bioinformatics and Cancer: Tools, Resources, and Biology

Cellular, Molecular, and Tumor Biology 97: Cell Surface Receptor Signaling

Cellular, Molecular, and Tumor Biology 98: Mechanisms of Apoptosis

Cellular, Molecular, and Tumor Biology 99: DNA Methylation Profiles

Chemistry 1: Chemical Topics in Drug Therapy, Radiation Therapy, Imaging, and Structure Biology

Chemistry 2: Chemical Aspects of Carcinogenesis

Chemistry 3: DNA as a Target for Drugs and Carcinogens

Chemistry 4: SAR and Structural Biology Studies of Drug Candidates

Chemistry 5: Proteomics and Chemistry

Clinical Research 1: Drug Resistance, Pharmacogenomics, and Pharmacokinetics

Clinical Research 10: Early Detection: Strategies and Technologies

Clinical Research 10:: Early Detection: Strategies and Technologies

Clinical Research 11: Clinical Investigations II: Gastrointestinal Cancers/Head and Neck Cancers/Hormone-related Cancers/ Leukemia and Lymphoma

Clinical Research 12: Clinical Investigations III: Lung Cancer/Ovarian and Other Gynecologic Cancers

Clinical Research 13: Clinical Investigations IV: Prostate and Other Genitourinary Cancers

Clinical Research 14: Clinical Pharmacology/Pharmacogenomics

Clinical Research 15: Clinical Investigations V: Brain and Other CNS Tumors/Breast Cancer/Melanoma

Clinical Research 16: Molecular and Morphologic Tumor Staging/Imaging

Clinical Research 17: Global Molecular Classification and Diagnosis

Clinical Research 2: Molecular Diagnosis and Prognosis I

Clinical Research 3: Molecular Classification of Tumors

Clinical Research 4: Molecular Diagnosis and Prognosis II

Clinical Research 5: Emerging Concepts and Targets in Immunotherapy

Clinical Research 6: Novel Prognostic and Predictive Factors

Clinical Research 7: Molecular Markers of Metastasis and Progression

Clinical Research 8: Laboratory Correlates/New Targeted Agents/Methodology for New Study Design

Clinical Research 9: Molecular Detection of Metastasis and Genetic Alteration in Cancer

Educational Session: Advances in High-Throughput Genotyping

Educational Session: Biologic Agents as Radiation Response Modifiers

Educational Session: Chemical Biology in Anticancer Drug Discovery

Educational Session: Chromatin Structure and Function in Cancer

Educational Session: Hypoxia: Impact on Cancer Biology

Educational Session: Molecular Imaging Strategies

Educational Session: Registration Strategies in Cancer Drug Development: Opportunities and Challenges

Educational Session: Research Paradigms in Anticancer Drug Discovery and Development

Educational Session: RNA Interference: A Tool for Gene Silencing

Educational Session: Stem Cells and Cancer

Educational Session: Structural Biology and Its Practical Aspects in Drug Discovery

Educational Session: Studying Genetic Modifiers in Experimental and Human Cancer

Educational Session: Targeting Signal Transduction Pathways

Educational Session: Zebrafish as an Animal Model in Cancer Research

Endocrinology 1: Endocrinology I

Endocrinology 2: Endocrinology II

Endocrinology 3: Endocrinology III

Endocrinology 4: Endocrinology IV

Endocrinology 5: Endocrinology V

Epidemiology 1: Viral, Bacterial, and Dietary Exposures

Epidemiology 10: Smoking and Cancer: Lung, Head and Neck, and Bladder Cancer

Epidemiology 11: Genetic Epidemiology of Breast, Prostate, and Gynecologic Cancers: Hormone and Carcinogen Metabolism

Epidemiology 12: Polymorphisms in Diverse Genes Associated with Gastrointestinal Lesions

Epidemiology 13: Genetic Susceptibility to Squamous and Transitional Cell Cancers

Epidemiology 2: Epidemiology of Breast and Prostate Cancer

Epidemiology 3: Immune Response and Exposure Modifying Genes in Diverse Neoplasms

Epidemiology 4: DNA Repair Genotype/Phenotype II

Epidemiology 5: Biomarkers of Human Exposure to Carcinogens

Epidemiology 6: Endogenous and Exogenous Factors in Breast and Prostate Cancer

Epidemiology 7: DNA Repair Genotype/Phenotype I

Epidemiology 8: Methods, Genotype/Phenotype and Carcinogen Metabolism Genes

Epidemiology 9: Risk Factors and Modeling

Experimental and Molecular Therapeutics 1: ABC Transporters in Drug Resistance

Experimental and Molecular Therapeutics 10: Novel Mechanisms of Drug Resistance

Experimental and Molecular Therapeutics 11: Specific Immune Mechanisms and Cancer Vaccines: Clinical Studies

Experimental and Molecular Therapeutics 12: New Targets, Agents, and Delivery Strategies

Experimental and Molecular Therapeutics 13: Novel Therapeutic Agents I

Experimental and Molecular Therapeutics 14: Investigational Combinations/Modulators II

Experimental and Molecular Therapeutics 15: Molecular Pharmacology, Pharmacokinetics and Pharmacogenomics

Experimental and Molecular Therapeutics 16: Novel Agents: Targets and Mechanisms

Experimental and Molecular Therapeutics 17: Novel Screens/Targets and Dosing Approaches

Experimental and Molecular Therapeutics 18: Pharmacogenomics, Preclinical Toxicology, Pharmacokinetics

Experimental and Molecular Therapeutics 19: Reversing or Overcoming Drug Resistance

Experimental and Molecular Therapeutics 2: Drug Accumulation and Metabolism as Mechanisms of Drug Resistance

Experimental and Molecular Therapeutics 20: Gene Expression Profiling of Drug Action

Experimental and Molecular Therapeutics 21: Cell Cycle Checkpoint and Kinase Inhibition

Experimental and Molecular Therapeutics 22: Novel Strategies for Gene Delivery

Experimental and Molecular Therapeutics 23: Histone Deacetylase Inhibitors

Experimental and Molecular Therapeutics 24: Novel Mechanisms of Drug Resistance and Functional Characterization

Experimental and Molecular Therapeutics 25: Apoptotic Pathways and the Immune System

Experimental and Molecular Therapeutics 26: Molecular Targets of Antimetabolites

Experimental and Molecular Therapeutics 27: Natural Products

Experimental and Molecular Therapeutics 28: Novel Targets and Approaches for Angiogenesis and Signaling Pathways

Experimental and Molecular Therapeutics 29: Novel Therapeutic Agents II

Experimental and Molecular Therapeutics 3: Investigational Combinations/Modulators I

Experimental and Molecular Therapeutics 30: Target Identification

Experimental and Molecular Therapeutics 31: Topoisomerase, Telomerase, and Nucleosides/Nucleotides

Experimental and Molecular Therapeutics 32: Cellular Pharmacology and Pharmacogenomics

Experimental and Molecular Therapeutics 33: Gene Therapy II

Experimental and Molecular Therapeutics 34: Genes, Drugs, and Novel Agents

Experimental and Molecular Therapeutics 35: Preclinical Models/Pharmacology/Mechanisms

Experimental and Molecular Therapeutics 36: Signal Transduction Inhibitors

Experimental and Molecular Therapeutics 37: Signaling Targets

Experimental and Molecular Therapeutics 38: Novel Therapeutic Agents III: Signaling Inhibitors

Experimental and Molecular Therapeutics 39: Novel Therapeutic Agents IV: Small Molecule Inhibitors

Experimental and Molecular Therapeutics 4: Mechanisms of Action

Experimental and Molecular Therapeutics 40: Proteosome Inhibition and Histone Deacetylase Inhibitors

Experimental and Molecular Therapeutics 41: Antiangiogenesis

Experimental and Molecular Therapeutics 42: Cell and Stroma-directed New Agents

Experimental and Molecular Therapeutics 43: Gene Therapy III

Experimental and Molecular Therapeutics 44: Platinum Compounds/Antimetabolites/Taxanes

Experimental and Molecular Therapeutics 45: Small Molecules: Signaling and Apoptosis Targets

Experimental and Molecular Therapeutics 46: Cell Signaling Inhibitors

Experimental and Molecular Therapeutics 47: Cellular Responses to Anticancer Drugs

Experimental and Molecular Therapeutics 48: Growth Factor Receptors as Therapeutic Targets

Experimental and Molecular Therapeutics 49: Molecular Targeted Agents

Experimental and Molecular Therapeutics 5: Molecular Profiling of Drug Resistance

Experimental and Molecular Therapeutics 50: New Approaches to Classic Targets

Experimental and Molecular Therapeutics 51: Pharmacokinetics and Pharmacodynamics

Experimental and Molecular Therapeutics 52: Tubulin-targeted Agents

Experimental and Molecular Therapeutics 53: Microtubule Inhibitors

Experimental and Molecular Therapeutics 54: Small Molecules: Cell Cycle and Signaling Inhibitors

Experimental and Molecular Therapeutics 6: Novel Delivery Strategies

Experimental and Molecular Therapeutics 7: Cellular Responses to Alkylating Agents

Experimental and Molecular Therapeutics 8: Diagnostic Markers, Imaging, and Microarrays

Experimental and Molecular Therapeutics 9: Gene Therapy I

Immunology/Tumor Immunobiology 1: Lymphokines, Cytokines, and Growth Factors in Tumor Immunity I

Immunology/Tumor Immunobiology 10: Cancer Vaccines: Preclinical Studies

Immunology/Tumor Immunobiology 11: Tumor Antigens and Animal Models for Immunotherapy I

Immunology/Tumor Immunobiology 12: Tumor Antigens and Animal Models for Immunotherapy II

Immunology/Tumor Immunobiology 2: Tumors and the Immune System: Immunotherapy and Immunomodulation I

Immunology/Tumor Immunobiology 3: Specific Immunomechanisms and Cancer Vaccines: Basic Studies I

Immunology/Tumor Immunobiology 4: Specific Immunomechanisms and Cancer Vaccines: Basic Studies II

Immunology/Tumor Immunobiology 5: Tumors and the Immune System: Immunotherapy and Immunomodulation II

Immunology/Tumor Immunobiology 6: Molecular and Cellular Mechanisms of Antitumor Immunity

Immunology/Tumor Immunobiology 7: Innovative Approaches to Immunotherapy of Tumors

Immunology/Tumor Immunobiology 8: Lymphokines, Cytokines, and Growth Factors in Tumor Immunity II

Immunology/Tumor Immunobiology 9: Specific Immunomechanisms and Cancer Vaccines: Basic Studies III

Integrated Session 1: Growth Factors and Antibodies in Tumor Immunotherapy

Integrated Session 10: Human Prevention/Screening Studies

Integrated Session 11: Proteomics

Integrated Session 2: Cell Signaling and Apoptosis after Radiation

Integrated Session 3: Clinical Cancer Genetics

Integrated Session 4: Clinical Prevention Studies

Integrated Session 5: Modification of Radiation Sensitivity

Integrated Session 6: Immunotherapy and Combined Modality Approaches

Integrated Session 7: Pediatric Oncology

Integrated Session 8: Radiation: Normal Tissue Damage, Protectors, and Predictive Assays

Integrated Session 9: Racial and Ethnic Minorities and the Medically Underserved: Multidisciplinary Research into Biology, Outcomes, and Disparities

Opening Plenary Session: Targeting the Conquest of Cancer through Conceptual Integration and Innovation

Prevention Research 1: Chemoprevention Studies I

Prevention Research 10: Biomarkers and Intervention Studies

Prevention Research 2: Biological and Biochemical Mechanisms in Prevention

Prevention Research 3: Molecular Targets for Cancer Prevention: Development of New Agents

Prevention Research 5: Chemoprevention Studies II

Prevention Research 6: Molecular Markers in Prevention Research

Prevention Research 7: Diet and Cancer

Prevention Research 8: Mechanistic Pathways Modulated by Natural Products

Prevention Research 9: New Agents and Mechanisms in Chemoprevention of Prostate and Breast Cancer

Supportive Care and Survivorship Research 1: Psychosocial Research in Cancer

Symposium: Cellular and Molecular Determinants of Metastasis

Symposium: Challenges for Integrating Targeted Therapies

Symposium: DNA Damage Signaling

Symposium: Genetic Model Systems to Dissect Cancer

Symposium: Genetic Modifiers of Cancer Risk

Symposium: Genomic and Chromosomal Instability

Symposium: Nuclear Receptors and Cancer Prevention

Symposium: Obesity, Metabolism and Cancer

Symposium: Outside-In Signaling in Cancer

Symposium: Pharmacogenomics and Response Prediction

Symposium: Role of DNA Repair Genotype and Phenotype in Cancer Susceptibility

Symposium: Systems Biology of Cancer: The Tumor as an Organ

Symposium: The Ubiquitin-Proteasome System and Cancer

to come

All Issues

Advertisement

Email alerts

eTOC Alert
Close Modal
Breaking
T-DXd Successfully Controls Brain Metastases
Subcutaneous PD-1 Injection Potential Boon for Patients
Don’t Rechallenge with an ICI in Renal Cell Carcinoma
View more recent articles
Latest News
Short-Term Exposure to Air Pollution May Drive Lung Cancer in Never-Smokers
Insufficient Genetic Data Forbode Trial Stoppages
Evidence Points to the Value of Neoadjuvant Therapy for NSCLC
View more recent articles
Research Watch
Post-Fast Refeeding Drives Stem Cell Regeneration via Polyamine Metabolism
The Fanconi Anemia Pathway Mediates Chromothripsis and Resistance to Cancer Therapy
X Chromosome Translocations Drive Sex Bias in a Rare Kidney Cancer Subtype
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1538-7445
  • Print ISSN 0008-5472

AACR Journals

 

 

  • Copyright © 2023 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept